Related Experiment Video
Updated: May 28, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents
Koneni V Sashidhara1, Manoj Kumar, Ram K Modukuri
1Medicinal and Process Chemistry Division, Central Drug Research Institute (CSIR-CDRI), Lucknow 226 001, India. kv_sashidhara@cdri.res.in
Abstract:
The synthesis of a series of benzocoumarin keto-enamine schiff bases is reported. The novel compounds were evaluated for their antihyperlipidemic activity in the hyperlipidemic hamster model. The compound 11 at a dose of 10 mg/kg body weight significantly lowered the plasma triglyceride levels (TG) by 70%, total cholesterol (TC) by 47%, accompanied by an increase in HDL-C/TC ratio by 80% in hyperlipidemic hamsters to a greater degree than the reference drugs atorvastatin and lovastatin.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Directing and Steric Effects in Disubstituted Benzene Derivatives
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholinergic Antagonists: Pharmacokinetics